Hugh M. Davis

Insider Reports History

Entity
Individual
Location
C/O Aclaris Therapeutics, Inc., 701 Lee Road, Suite 103, Wayne, PA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hugh M. Davis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. President and COO, Director Restricted Stock Units 107K $435K $4.07 Dec 2, 2024 Direct
Aclaris Therapeutics, Inc. President and COO, Director Employee Stock Option (Right to Buy) 375K Dec 2, 2024 Direct

Insider Reports Filed by Hugh M. Davis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Dec 2, 2024 2 $0 4 Dec 3, 2024 President and COO, Director
ACRS Aclaris Therapeutics, Inc. Nov 18, 2024 0 $0 3 Nov 18, 2024 President and COO, Director